Our latest white paper on Literature Monitoring Challenges and Opportunities is out. Get it here!
biologit Media
On demand
Talks and Webinars
How to Optimize the Literature Review for Medical Devices for EU MDR Compliance
Nicole Baker
The MedTech regulatory landscape is rapidly evolving and literature review plays a key role in meeting requirements.
AI in Pharmacovigilance (Summer 2023)
Nicole Baker
In this webinar Nicole Baker (CEO) discusses advances in AI for pharmacovigilance, the regulatory landscape and the biologit MLM-AI solution for literature screening powered by AI.
AI Regulatory guidance and transparency
Bruno Ohana
Across many industries the regulatory landscape for deploying ML systems is still evolving: with many so frameworks and proposals being put forward, how do practitioners make progress?
Documentation for AI: Case Study in Pharmacovigilance
Bruno Ohana
How can good documentation practices improve quality, reduce risks and ensure compliance? Bruno Ohana presents a case study that applies AboutML principles conducted in collaboration with the Partnership on AI.
biologit Podcasts
Innovation and the Future of Pharmacovigilance
Nicole Baker
Embark on a captivating journey with Nicole Baker, the pioneering CEO of Biologic, as she shares her remarkable transition from academia to the forefront of pharmacovigilance on Truliant Talks. Nicole's narrative is not just about her personal evolution but also serves as an illuminating guide through the labyrinth of safety regulations and drug monitoring.
The Use of AI for Medical Literature Monitoring
Nicole Baker
Nicole Baker introduces the topic of pharmacovigilance and how biologit seeks to use AI to help ensure safety when it comes to prescribing and using medicines.
Tripod: Pharmacovigilance
Nicole Baker
biologit CEO Nicole Baker discusses the topic “Making Clinical Drugs Safer through use of AI”: protecting the patient through linking Pharmacovigilance with Computer Science. Using artificial intelligence to search medical literature, practice, and real world data around the safety of clinical drug use.